Finance

Lists
ALKEM:NSE
Alkem Laboratories Ltd
₹5,677.00
-1.30%
(-74.50) 1D
Aug 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
₹5,774.50
High
₹5,774.50
Low
₹5,668.00
Mkt. cap
678.77B
Avg. vol.
153.89K
Volume
122.66K
Dividend
0.93%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
29.49
52-wk high
₹5,933.50
52-wk low
₹4,738.50
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
Open
₹5,774.50
High
₹5,774.50
Low
₹5,668.00
Mkt. cap
678.77B
Avg. vol.
153.89K
Volume
122.66K
Dividend
0.93%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 7, 2026
P/E ratio
29.49
52-wk high
₹5,933.50
52-wk low
₹4,738.50
EPS
₹192.51
Shares outstanding
119.55M
No. of employees
19K
News stories
From sources across the web
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19.3K
Founded1973
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Next call in 11 days
Fri, Aug 14, 1:00 PM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹47.04
Revenue / Est. (INR)
- / 37.96B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
33.71B
40.01B
37.37B
36.03B
Cost of goods sold
11.71B
14.01B
12.73B
14.33B
Cost of revenue
11.71B
14.01B
12.73B
14.33B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.93B
7.10B
7.22B
17.12B
Operating expense
15.49B
17.73B
17.31B
17.80B
Total operating expenses
27.20B
31.74B
30.04B
32.13B
Operating income
6.51B
8.27B
7.33B
3.90B
Other non operating income
1.36B
1.04B
1.43B
-3.55B
EBT including unusual items
7.71B
8.95B
7.81B
4.22B
EBT excluding unusual items
7.58B
8.95B
8.33B
4.77B
Income tax expense
1.03B
1.16B
1.28B
1.71B
Effective tax rate
13.33%
12.98%
16.35%
40.53%
Other operating expenses
7.68B
9.69B
9.15B
-378.70M
Net income
6.64B
7.65B
6.36B
2.36B
Net profit margin
19.70%
19.12%
17.02%
6.56%
Earnings per share
54.62
63.99
56.88
26.50
Interest and investment income
-
-
-
3.92B
Interest expense
-297.80M
-350.20M
-421.00M
-336.50M
Net interest expenses
-297.80M
-350.20M
-421.00M
3.58B
Depreciation and amortization charges
876.80M
936.10M
950.10M
1.06B
EBITDA
7.29B
9.18B
8.11B
4.67B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps